Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering ...
The Stelo glucose monitor for people with diabetes who are not taking insulin. [Image courtesy of Dexcom] After a busy 2024, Dexcom (Nasdaq:DXCM) Chair and CEO Kevin Sayer believes the company is set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback